Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Saskia Luelmo"'
Autor:
Derk C.F. Klatte, Bas Boekestijn, Anke M. Onnekink, Friedo W. Dekker, Lydia G. van der Geest, Martin N.J.M.M. Wasser, Shirin Feshtali, J. Sven D. Mieog, Hans Morreau, Thomas P. Potjer, Akin Inderson, Jurjen J. Boonstra, Hans F.A. Vasen, Saskia Luelmo, Jeanin E. van Hooft, Bert A. Bonsing, Monique E. van Leerdam
Publikováno v:
Journal of Clinical Oncology. 41:690-690
690 Background: Recent pancreatic cancer surveillance programs of high-risk individuals have reported improved outcomes. This study assessed to what extent outcomes of pancreatic ductal adenocarcinoma (PDAC) in patients with a CDKN2A/p16 pathogenic v
Autor:
Derk Klatte, Bas Boekestijn, Martin Wasser, Shirin Shahbazi Feshtali, Isaura Ibrahim, J.S. Mieog, Saskia Luelmo, Hans Morreau, Thomas Potjer, Akin Inderson, Jurjen Boonstra, Friedo Dekker, Hans F. Vasen, Jeanin E. Van Hooft, Bert A. Bonsing, Monique Van Leerdam
Publikováno v:
Gastroenterology. 162:S-51
Autor:
Emma C. Hulshof, Mirjam de With, Femke M. de Man, Geert-Jan Creemers, Birgit ALM Deiman, Jesse J. Swen, Saskia Houterman, Stijn L.W. Koolen, Marjan Laven, Saskia Luelmo, Ron H.N. van Schaik, Henk-jan Guchelaar, Ron H.J. Mathijssen, Hans Gelderblom, Maarten J. Deenen
Publikováno v:
Journal of Clinical Oncology. 39:3574-3574
3574 Background: Irinotecan is commonly used in the treatment of advanced colorectal and pancreatic cancer. The polymorphisms UGT1A1*28 (7 TA repeats) and UGT1A1*93 (SNP -3156G > A) are significantly associated with increased systemic exposure of iri